Evidence map›Paper›PMID 34411087›Full record

ArticleOncology nursing forum2021

Psycholinguistic Screening for Cognitive Decline in Cancer Survivors: A Feasibility Study.

Kristine Williams, Jamie S Myers, Jinxiang Hu, Alana Manson, Sally L Maliski

Open access · greenAbstract read
In one paragraph

Article in Oncology nursing forum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kristine WilliamsUniversity of Kansas Medical Center.
Jamie S MyersUniversity of Kansas Medical Center.
Jinxiang HuUniversity of Kansas Medical Center.
Alana MansonUniversity of Kansas Medical Center.
Sally L MaliskiUniversity of Kansas Medical Center.
University of Kansas Medical Center · US

Funding

HEARTLAND INSTITUTE FOR CLINICAL AND TRANSLATIONAL RESEARCHUL1RR033179 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BAROHN, RICHARD J. · 2011 to 2011
$3.2M
Heartland Institute for Clinical and Translational ResearchKL2RR033177 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BAROHN, RICHARD J. · 2011 to 2011
$653k
NCRR NIH HHS KL2 RR033177NCRR NIH HHS UL1 RR033179
6 · The paper itself

Abstract

objectivesTo test the feasibility of using psycholinguistic speech analysis as a proxy for cognitive function in men undergoing treatment for prostate cancer. SAMPLE &

settingAudio-recorded speech samples were collected from 13 men enrolled in a parent study at the University of Kansas Cancer Center in Kansas City. METHODS & VARIABLES: Audio-recorded speech samples, collected from clinical interviews and in response to a prompt question during the parent study at two time points, were evaluated to determine feasibility relationships between neurocognitive and psycholinguistic measures.

resultsCorrelations between neurocognitive and psycholinguistic measures were identified for prompted speech, but the strength of relationships varied between time points. No relationships were identified in clinical interview speech samples. IMPLICATIONS FOR NURSING: Feasibility was demonstrated for recording, transcribing, and analyzing speech from clinical interviews, and results suggest relationships between neurocognitive and psycholinguistic measures in prompted speech. If validated, psycholinguistic assessments may be used to assess cognitive function in cancer survivors. Advances in natural language processing may provide opportunities for automated speech analyses for cancer treatment-related cognitive decline.

Indexed as

Cancer SurvivorsCognitive DysfunctionNeoplasmsCognitionEarly Detection of CancerFeasibility StudiesHumansMalePsycholinguisticscancer treatmentcognitioncognitive declinepsycholinguistic screeningspeech analysis

Identifiers

PMID34411087
PMCPMC8442169
OpenAlexW3193458933

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.